Drug Discovery Today: how the transition from preclinical research to clinical trials can impact biotech valuations
A recent study published in Drug Discovery Today by Thomas Thurston and Hubert Truebel found low odds of success for biotech startups that raise more than four funding rounds before starting their clinical trials. Highlights: Analysis of 233 biotech startups at various stages, and - separately - 238 biotech startups that were ultimately acquired or had and IPO. There was…